KNW: Instrument, Biopsy

Product code KNW, “Instrument, Biopsy” in FDA's classification database, is a Class II device type under 21 CFR 876.1075 (gastroenterology-urology biopsy instrument), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 365 clearances under KNW, 123 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
KNW
Regulation
21 CFR 876.1075
Class
II
Panel
Gastroenterology, Urology
Clearances
365
Most recent
Aug 28, 2026
Median review, last 2 years
165 days
Third-party review
Eligible
Implant
No

What it covers

A gastroenterology-urology biopsy instrument is a device used to remove, by cutting or aspiration, a specimen of tissue for microscopic examination. This generic type of device includes the biopsy punch, gastrointestinal mechanical biopsy instrument, suction biopsy instrument, gastro-urology biopsy needle and needle set, and nonelectric biopsy forceps. This section does not apply to biopsy instruments that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.

The identification in 21 CFR 876.1075, gastroenterology-urology biopsy instrument. FDA gives KNW no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K260517Automatic Core Biopsy InstrumentZhejiang Curaway Medical Technology Co., Ltd.Aug 28, 2026Traditional
K262571EnCor EnCompass™ Breast Biopsy and Tissue Removal SystemBard Peripheral Vascular, Inc.Aug 14, 2026Special
K262792Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09)Hologic, Inc.Aug 12, 2026Special
K260572Marrow MarxmanMedimetrix, LLCAug 4, 2026Traditional
K261196Promisemed VeriEcto Automatic Biopsy NeedlesPromisemed Hangzhou Meditech Co., Ltd.May 12, 2026Special
K260365Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Control Module; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Disposable Probe, 8 gauge; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Disposable Targeting Set, 8 gauge; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Foot Switch; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Reusable Tray; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Battery CharDevicor Medical Products, Inc.Mar 4, 2026Traditional
K252795ZeniCore™ Automatic Biopsy Instrument (863212100 / ZeniCore Automatic Biopsy Device 12ga x 10cm with Coaxial Introducer Kit); ZeniCore™ Automatic Biopsy Instrument (863212130 / ZeniCore Automatic Biopsy Device 12ga x 13cm with Coaxial Introducer Kit); ZeniCore™ Automatic Biopsy Instrument (863214100 / ZeniCore Automatic Biopsy Device 14ga x 10cm with Coaxial Introducer Kit); ZeniCore™ Automatic Biopsy Instrument (863214130 / ZeniCore Automatic Biopsy Device 14ga x 13cm with CoaxialArgon Medical Devices, Inc.Feb 23, 2026Traditional
K252681EnCor EnCompass™ Breast Biopsy and Tissue Removal SystemBard Peripheral Vascular, Inc.Dec 12, 2025Traditional
K252183Resitu Slider 09 (RESL09)Resitu Medical ABSep 24, 2025Traditional
K243407Forcyte Autograft Harvest KitForcyte Medical, LLCJul 29, 2025Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 365 with a free account)

Clearances by year

123 KNW 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)729
202512178
20245114
20237164
20228203
2021954
2020892
2019594
2018771
2017890
20169127
201510106
2014895
20133100
2012794
20111064

Who submits

71 applicants cleared a KNW device since 2011. 71% of the clearances went to applicants in United States, then China (11%), Italy (7%) and Sweden (4%). By type: Traditional 80% and Special 20%. 6 went through a third-party review organization.

ApplicantClearances since 2011
Devicor Medical Products, Inc.7
Bard Peripheral Vascular, Inc.6
Medax Srl Unipersonale5
Hologic, Inc.4
Ranfac Corporation4
Stryker Corporation4
Zhejiang Curaway Medical Technology Co., Ltd.4
Avitus Orthopaedics, Inc.3

How FDA classifies it

(1) Class II (performance standards).

(2) Class I for the biopsy forceps cover and the non-electric biopsy forceps. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.

From 21 CFR 876.1075. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 876.1075 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent KNW clearances declared.

Ask about KNW

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about KNW

What is FDA product code KNW?

Product code KNW, “Instrument, Biopsy” in FDA's classification database, is a Class II device type under 21 CFR 876.1075 (gastroenterology-urology biopsy instrument), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 365 clearances under KNW, 123 of them since 2011.

How many 510(k) clearances are there under KNW?

FDA’s 510(k) database listed 365 clearances under KNW as of Oct 29, 2026, 123 of them decided since 2011; the most recent decision was Aug 28, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a KNW 510(k)?

For the 20 KNW clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 165 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most KNW clearances?

Since 2011: Devicor Medical Products, Inc. (7), Bard Peripheral Vascular, Inc. (6), Medax Srl Unipersonale (5), Hologic, Inc. (4) and Ranfac Corporation (4). 71 applicants have cleared a KNW device in that time.

Sources

  1. FDA product classification: KNW · Product Classification database
  2. 21 CFR 876.1075: Gastroenterology-urology biopsy instrument · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for KNW · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow KNWGet an email when FDA clears, recalls or publishes guidance for KNW devices.

Know what FDA already cleared.